Psychopharmacology: the need for effectiveness trials to inform evidence-based psychiatric practice.
Lagomasino
Isabel T
IT
University of Southern California Keck School of Medicine, 2020 Zonal Avenue, IRD 218, Los Angeles, California 90033, USA. lagomasi@usc.edu
Dwight-Johnson
Megan
M
Simpson
George M
GM
D003362:Cost-Benefit Analysis / Q000706:statistics & numerical data; D016527:Drug Costs / Q000706:statistics & numerical data; D019317:Evidence-Based Medicine; D006301:Health Services Needs and Demand / Q000191:economics / Q000706:statistics & numerical data*; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000191:economics; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D019057:Quality-Adjusted Life Years; D016032:Randomized Controlled Trials as Topic / Q000191:economics / Q000706:statistics & numerical data*; D015983:Selection Bias; D016896:Treatment Outcome; D014481:United States
D011619:Psychotropic Drugs